Discordance Between Clinicopathological and Molecular Risk Classification in Endometrial Carcinoma: A Prospective Observational Study
Background: Endometrial carcinoma is commonly managed using clinicopathological risk stratification to guide adjuvant treatment. However, p53 and mismatch repair (MMR) status may identify biological risks not captured by conventional classifications. Local evidence regarding discordance between clinicopathological and...